Patent · US Expired

Lipid-lowering quinazoline derivative

US6172071A · kind A · utility

6Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 1998
Grant dateJan 9, 2001
Priority date—
Expiry dateJul 30, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A novel carbonyl-substituted quinazoline, preferably 4-(3'-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), and methods for lowering blood cholesterol, including reducing total cholesterol and LDL-cholesterol levels by administration of the carbonyl quinazolines and compositions thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.